Pharmacy on Web

wintersales_clearance

Your Shopping Cart




Your Cart is currently empty.

   

You are here: Home Pharmacy News The most popular PPI To Stay In the NZ Market
Decrease font size  Default font size  Increase font size 
The most popular PPI To Stay In the NZ Market

30 September 2008

A fully funded generic Omeprazole will replace AstraZenecas Proton Pump inhibitor (PPI) Losec from January 2009 as part of Pharmac's plan in reducing the pharmaceutical expenditure in new Zealand.

Dr Reddys Omeprazole has been awarded sole supplier status by Pharmac. Currently in community pharmacy throughout NZ, Dr Reddys Pantoprazole has already replaced the popular proton inhibitor Somac (Pfizer) which is no longer available in the New Zealand market.

Aztrazenca, are advising pharmacies that they will continued to make Losec available in NZ via the private market, so essentially you will need to pay out of your own pocket if you want to keep taking Losec. 

Planning ahead, here is the dates for Losec changes.

 

Date

Funding Status

Current to 1 January 2009

Fully Funded

1January to 30 April 2009

Partly Subsidised

From 1 May 2009

User Pays

 

 

 
Subscribe our Newsletter and receive the latest news and great deals.




SSL